Tomasz Huzarski

发表

Vitamin D receptor variants and the malignant melanoma risk: a population-based study | NOVA. The University of Newcastle's Digital Repository

Rodney J. Scott, P. Gapska, Romuald Maleszka, 2009 .

Screening with magnetic resonance imaging, mammography and ultrasound in women at average and intermediate risk of breast cancer

Tomasz Huzarski, Andrzej Mackiewicz, Cezary Cybulski, 2017, Hereditary cancer in clinical practice.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Christiana Kartsonaki, Mads Thomassen, Etienne Rouleau, 2011, Human molecular genetics.

Immunophenotypic predictive profiling of BRCA1-associated breast cancer

Pawel Domagala, Jan Lubinski, Tomasz Huzarski, 2010, Virchows Archiv.

Germline RECQL mutations are associated with breast cancer susceptibility

Aniruddh Kashyap, Jacek Majewski, Javad Nadaf, 2015, Nature Genetics.

Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170

Wei Zheng, Mads Thomassen, Nicholas A. Sinnott-Armstrong, 2016 .

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population

Christiana Kartsonaki, Mads Thomassen, Julian Peto, 2010, Nature Genetics.

The risk of breast cancer in women with a BRCA1 mutation from North America and Poland

Susan L Neuhausen, Jan Lubinski, Kevin Sweet, 2012, International journal of cancer.

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.

Patrick Neven, Päivi Heikkilä, Giu-Cheng Hsu, 2011, Human molecular genetics.

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.

Val Gebski, Philipp Harter, Tomasz Huzarski, 2017, The Lancet. Oncology.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Mads Thomassen, Nina Ditsch, Muhammad Usman Rashid, 2015, JAMA.

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

Patrick Neven, Peter Kraft, Nazneen Rahman, 2015 .

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study

Charis Eng, Fergus Couch, Kevin Sweet, 2013, British Journal of Cancer.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Mads Thomassen, Etienne Rouleau, Dieter Niederacher, 2010, Cancer research.

Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk

Thilo Dörk, Natalia Bogdanova, Tadeusz Dębniak, 2009, Breast Cancer Research and Treatment.

BRCA1 mutations and colorectal cancer in Poland

Anna Jakubowska, Rafał Wiśniowski, Tadeusz Dębniak, 2010, Familial Cancer.